Type 2 Diabetes Trial, Recruiting (NCT06638567)

Type 2 Diabetes Trial, Recruiting NCT06638567 Sponsor: Abraham Hulst, MD, PhD Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06638567 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older
People who have been diagnosed with type 2 diabetes
People who are having gastrointestinal (digestive system) or vascular (blood vessel) surgery
People admitted to one of the hospital wards taking part in this trial
People expected to stay in hospital for at least one night
People who are willing and able to give their formal agreement to take part

Who may not be able to join:

People who have been diagnosed with type 1 diabetes
Women who are pregnant or breastfeeding, or who could become pregnant
People having a complete removal of the pancreas
People having weight-loss (bariatric) surgery
People who use a continuous insulin pump at home
People having surgery to remove dead tissue or clean a pre-existing wound

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sarah E. Siegelaar, MD, PhD, Amsterdam UMC, location AMC

Phone: 0031205669111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06638567

Sponsor: Abraham Hulst, MD, PhD

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 0031205669111

More information: https://clinicaltrials.gov/study/NCT06638567

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older
People who have been diagnosed with type 2 diabetes
People who are having gastrointestinal (digestive system) or vascular (blood vessel) surgery
People admitted to one of the hospital wards taking part in this trial
People expected to stay in hospital for at least one night
People who are willing and able to give their formal agreement to take part

Who may not be able to join:

People who have been diagnosed with type 1 diabetes
Women who are pregnant or breastfeeding, or who could become pregnant
People having a complete removal of the pancreas
People having weight-loss (bariatric) surgery
People who use a continuous insulin pump at home
People having surgery to remove dead tissue or clean a pre-existing wound

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Abraham Hulst, MD, PhD

Registry

ClinicalTrials.gov

Start date

3 January 2025

Est. completion

1 February 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Surgical site infection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov